The Valley Desk

Case reportCureusPublished

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Lewis Katz School of Medicine, Temple University. Affiliation source

Publication record

Type
Case report
Venue
Cureus
Published
Subject terms
Monoclonal antibody; Psoriasis; Biologic Therapy; Generalized Pustular Psoriasis; Immunodermatology; Spesolimab; Il-36 Pathway
PubMed ID
41732608
PubMed Central ID
PMC12925328
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal